This page was translated automatically from Turkish. Read the original

Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun.

Nordik Perspektifler OturumuPerinatal ve Kadın SağlığıDerleme / görüş

The menopausal transition and women’s mental health: epidemiological evidence and emerging risk profiles

The menopause transition and women’s mental health: epidemiological evidence and emerging risk profiles

Sunan: Alexis E. Cullen

Ülke: Sweden

Oturum: 4020 - WOMEN’S MENTAL HEALTH ACROSS THE LIFE COURSE: FROM ADOLESCENCE TO MIDLIFE—POPULATION EVIDENCE AND PRECISION PREVENTION

Tarih: Fri, 25.09.2026, 17:00 - 17:15

Salon: Hall A7

The menopausal transition and menopausal symptoms can impose a substantial mental health burden, and register-based and evidence synthesis studies conducted in Sweden aim to characterize psychiatric comorbidities and risk profiles during this period.

The talk explores the impact of the menopausal transition, triggered by declining reproductive hormone levels, on women’s mental health. Approximately 50% of the world’s population will experience menopause. While the transition has little impact on some women, there is growing recognition that menopausal symptoms can significantly affect health and working life, prompting calls in Sweden and other countries to improve healthcare for women with severe perimenopausal and menopausal symptoms. The presentation describes register-based, evidence synthesis, and population-based studies conducted within the HER MIND network at Karolinska Institutet and the WHOLE research center at Uppsala University. It also features two programs led by the speaker: the MEMPHIS project, which uses register data to examine psychiatric comorbidities among women receiving treatment for menopause and perimenopause in Sweden, and Meno2mind, a multistage evidence synthesis project investigating the extent to which the menopausal transition and menopausal hormone therapies are associated with the onset, exacerbation, or improvement of mental disorders and their treatment. The talk also introduces studies examining perimenopausal mental health phenotypes, risk factors for severe mental illness in women of menopausal age, and the effects of estradiol on brain health during perimenopause. It concludes by outlining how the findings could inform mental health interventions for women of menopausal age and identifying remaining evidence gaps and priorities for future research.

Bu çalışmaya nasıl atıf yapılır?

APA 7: Cullen, A. E., et al. (2026, September 25). The menopause transition and women’s mental health: epidemiological evidence and emerging risk profiles [Oral presentation]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden.

Vancouver: Cullen AE, et al. The menopause transition and women’s mental health: epidemiological evidence and emerging risk profiles [oral presentation]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden.

Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın.

Tüm WCP 2026 özetleri

Sitenin son güncellemesi: 8 Kasım 2026 · Site editörü: Doç. Dr. Alişan Burak Yaşar, info@alisanburak.com